Trials / Completed
CompletedNCT03890887
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the Blood
Relative Bioavailability of a Single Oral Dose of BI 1291583 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects (an Open-label, Two-period, Fixed Sequence Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the relative bioavailability of BI 1291583 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1291583 | Tablet |
| DRUG | Itraconazole | Oral solution |
Timeline
- Start date
- 2019-04-12
- Primary completion
- 2019-07-29
- Completion
- 2019-07-29
- First posted
- 2019-03-26
- Last updated
- 2025-08-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03890887. Inclusion in this directory is not an endorsement.